Citi cuts EyePoint price target to $17 from $35, keeps Buy, stock down 67%

August 17, 2026 8:41 AM

Citi analyst Yigal Nochomovitz lowered his price target on EyePoint Pharmaceuticals (NASDAQ: EYPT) to $17.00 from $35.00, while maintaining a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found